{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:28:38Z","timestamp":1769826518058,"version":"3.49.0"},"reference-count":27,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Women with androgenic Polycystic Ovary Syndrome (PCOS) have increased endometrial cancer risk that cyclic progesterone will prevent; it may also reverse PCOS\u2019s neuroendocrine origins. This pilot study\u2019s purpose was to document 6-month experience changes in a woman with PCOS taking cyclic progesterone therapy because she was intolerant of combined hormonal contraceptive therapy, the current PCOS standard of care. A 31-year-old normal-weight woman with PCOS had heavy flow, irregular cycles, and was combined hormonal contraceptives-intolerant. She was prescribed cyclic oral micronized progesterone (OMP) (300 mg\/h.s. cycle days 14\u201327). She kept Menstrual Cycle Diary\u00a9 (Diary) records, starting with the 1st treatment cycle for six cycles; she was on no other therapy. Statistical analysis a priori hypothesized progesterone decreases high estradiol (E2) experiences (flow, cervical mucus, fluid retention, front-of-the-breast tenderness and anxiety); analysis focused on these. Our objectives: (1) changes from cycles 1 to 6 in E2-related experiences; and (2) follicular phase E2-related changes from cycle 1 (no therapy) to cycles 3 and 6. Materials and Methods: Data from consecutive Diaries were entered into an SPSS database and analyzed by Wilcoxon Signed Rank Test (Objective #1) within-person whole cycle ordinal data, and (Objective #2 follicular phase) repeated measures ANOVA. Results: Cyclic OMP was associated with regular, shorter cycles (\u00b1SD) (28.2 \u00b1 0.8 days). Comparison of cycles 1\u20136 showed decreased fluid retention (p = 0.001), breast tenderness (p = 0.002), and cervical mucus (p = 0.048); there were no changes in flow or anxiety. Fluid retention in the follicular phase also significantly decreased over time (F (1.2, 14.7) = 6.7, p = 0.017). Conclusions: Pilot daily Diary data suggest women with PCOS have improved everyday experiences on cyclic progesterone therapy. Larger prospective studies with more objective outcomes and randomized controlled trials of this innovative PCOS therapy are needed.<\/jats:p>","DOI":"10.3390\/medicina57101024","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T10:39:20Z","timestamp":1632739160000},"page":"1024","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS)\u2014A 6-Month Pilot Study of a Single Woman\u2019s Experience Changes"],"prefix":"10.3390","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7866-3419","authenticated-orcid":false,"given":"Sonia","family":"Shirin","sequence":"first","affiliation":[{"name":"Centre for Menstrual Cycle and Ovulation Research, Endocrinology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada"},{"name":"British Columbia Women\u2019s Health Research Institute, Vancouver, BC V6H 3N1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faye","family":"Murray","sequence":"additional","affiliation":[{"name":"Centre for Menstrual Cycle and Ovulation Research, Endocrinology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azita","family":"Goshtasebi","sequence":"additional","affiliation":[{"name":"Centre for Menstrual Cycle and Ovulation Research, Endocrinology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada"},{"name":"British Columbia Women\u2019s Health Research Institute, Vancouver, BC V6H 3N1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8098-3435","authenticated-orcid":false,"given":"Dharani","family":"Kalidasan","sequence":"additional","affiliation":[{"name":"Centre for Menstrual Cycle and Ovulation Research, Endocrinology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3232-0597","authenticated-orcid":false,"given":"Jerilynn C.","family":"Prior","sequence":"additional","affiliation":[{"name":"Centre for Menstrual Cycle and Ovulation Research, Endocrinology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada"},{"name":"British Columbia Women\u2019s Health Research Institute, Vancouver, BC V6H 3N1, Canada"},{"name":"Division of Endocrinology, Department of Medicine, University of British Columbia, Room 4111, 2775 Laurel Street, Vancouver, BC V5Z 1M9, Canada"},{"name":"School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cen.13795","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"89","author":"Teede","year":"2018","journal-title":"Clin. Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-Analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_3","first-page":"604","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"Teede","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.socscimed.2015.10.007","article-title":"Polycystic ovary syndrome in globalizing India: An ecosocial perspective on an emerging lifestyle disease","volume":"146","author":"Pathak","year":"2015","journal-title":"Soc. Sci. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","article-title":"Androgen Excess-Polycystic Ovary Syndrome Society: Position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome","volume":"109","author":"Dokras","year":"2018","journal-title":"Fertil. Steril."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1210\/jc.2016-1896","article-title":"Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS","volume":"101","author":"Dokras","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/humrep\/16.1.36","article-title":"Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome","volume":"16","author":"Falsetti","year":"2001","journal-title":"Hum. Reprod."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e021860","DOI":"10.1136\/bmjopen-2018-021860","article-title":"Assessing C reactive protein\/albumin ratio as a new biomarker for polycystic ovary syndrome: A case-control study of women from Bahraini medical clinics","volume":"8","author":"Kalyan","year":"2018","journal-title":"BMJ Open"},{"key":"ref_11","first-page":"582","article-title":"Polycystic ovary syndrome: Evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"83","author":"Pastor","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_12","unstructured":"Prior, J.C. (2018, November 29). The Case for A New PCOS Therapy. Available online: https:\/\/helloclue.com\/articles\/cycle-a-z\/the-case-for-a-new-pcos-therapy."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dml017","article-title":"The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome","volume":"12","author":"Blank","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ddmod.2020.11.008","article-title":"The central role of ovulatory disturbances in the etiology of androgenic polycystic ovary syndrome (PCOS)\u2014Evidence for treatment with cyclic progesterone","volume":"32","author":"Briden","year":"2020","journal-title":"Drug Discov. Today Dis. Model."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/jcem-58-2-378","article-title":"Progesterone modulation of pulsatile luteinizing hormone secretion in normal women","volume":"58","author":"Soules","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/humrep\/12.6.1156","article-title":"Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment","volume":"12","author":"Cheung","year":"1997","journal-title":"Hum. Reprod."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/jcem-45-4-798","article-title":"Pituitary-ovarian relationships in polycystic ovary syndrome","volume":"45","author":"Baird","year":"1977","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/bmj.290.6482.1617","article-title":"Progesterone and the premenstrual syndrome: A double blind cross-over trial","volume":"290","author":"Dennerstein","year":"1985","journal-title":"Br. Med. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fertnstert.2009.02.073","article-title":"The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome","volume":"94","author":"Livadas","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1210\/jc.2002-020294","article-title":"The effects of short-term medroxyprogesterone acetate and micronized progesterone on glucose metabolism and lipid profiles in patients with polycystic ovary syndrome: A prospective randomized study","volume":"87","author":"Bagis","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","unstructured":"Adashi, E.Y., Rock, J.A., and Rosenwaks, Z.E. (1996). Exercise-associated menstrual disturbances. Reproductive Endocrinology, Surgery and Technology, Raven Press."},{"key":"ref_22","unstructured":"ClinicaKey (2021, January 06). Drug Monograph Progesterone: Elsevier; 26 August 2020. Available online: https:\/\/www-clinicalkey-com.www.proxy.cpsbc.ca\/#!\/content\/drug_monograph\/6-s2.0-515."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0002-9343(94)90092-2","article-title":"Cyclic medroxyprogesterone treatment increases bone density: A controlled trial in active women with menstrual cycle disturbances","volume":"96","author":"Prior","year":"1994","journal-title":"Am. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09513599209024991","article-title":"Vaginal progesterone administration in physiological doses normalizes raised luteinizing hormone levels in patients with polycystic ovarian syndrome","volume":"6","author":"Buckler","year":"1992","journal-title":"Gynecol. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/01674820903276438","article-title":"Ovulation disturbances and mood across the menstrual cycles of healthy women","volume":"30","author":"Harvey","year":"2009","journal-title":"J. Psychosom. Obstet. Gynecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"138451","DOI":"10.1155\/2011\/138451","article-title":"Fluid Retention over the Menstrual Cycle: 1-Year Data from the Prospective Ovulation Cohort","volume":"2011","author":"White","year":"2011","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/23293691.2021.1901519","article-title":"Does Interest in Sex Peak at Mid-Cycle in Ovulatory Menstrual Cycles of Healthy, Community Dwelling Women? An 11-Month Prospective Observational Study","volume":"8","author":"Macbeth","year":"2021","journal-title":"Women Reprod. Health"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/10\/1024\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:05:19Z","timestamp":1760166319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/10\/1024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,26]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["medicina57101024"],"URL":"https:\/\/doi.org\/10.3390\/medicina57101024","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,26]]}}}